Degradability of superparamagnetic nanoparticles in a model of intracellular environment: Follow-up of magnetic, structural and chemical properties

Nanotechnology

Volumn 21, Issue 39, 2010, Pages

  Lévy, Michael ^a   Lagarde, Florence ^b   Maraloiu, Valentin Adrian ^b   Blanchin, Marie Geneviève ^b   Gendron, François ^c   Wilhelm, Claire ^a   Gazeau, Florence ^a  

^a UNIVERSITÉ PARIS DIDEROT   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSTITUT DES NANOSCIENCES DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC PH; ACUTE TOXICITY; BIOMEDICAL APPLICATIONS; CELLULAR ENVIRONMENT; CELLULAR IMAGING; CHELATING AGENT; DEGRADABILITY; IRON HOMEOSTASIS; IRON OXIDE NANOPARTICLE; IRON-BASED; LIVING CELL; LONG-TERM INTEGRITY; MAGHEMITE NANOPARTICLE; MAGNETIC NANOPARTICLES; MRI CONTRAST AGENTS; PHYSICAL STATE; SUPERPARAMAGNETIC NANOPARTICLES; SURFACE COATINGS;

CHELATION; CHEMICAL PROPERTIES; COATINGS; DEGRADATION; DISSOLUTION; IRON ORES; IRON OXIDES; MAGNETIC PROPERTIES; MAGNETIC RESONANCE; METAL RECOVERY; NANOCRYSTALS; NANOPARTICLES; SUPERPARAMAGNETISM;

NANOMAGNETICS;

CITRATE SODIUM; CITRIC ACID; CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE; MAGNETITE NANOPARTICLE;

ARTICLE; BIOLOGICAL MODEL; CHEMICAL MODEL; CHEMISTRY; LYSOSOME; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PH; SURFACE PROPERTY; TEMPERATURE; TIME; ULTRASTRUCTURE;

CITRATES; CONTRAST MEDIA; FERRIC COMPOUNDS; HYDROGEN-ION CONCENTRATION; LYSOSOMES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PARTICLE SIZE; SURFACE PROPERTIES; TEMPERATURE; TIME FACTORS;

EID: 77958614390     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/21/39/395103     Document Type: Article

References (41)

1. Corot C, Robert P, Idee J M and Port M 2006 Recent advances in iron oxide nanocrystal technology for medical imaging Adv. Drug Deliv. Rev. 58 1471-504
2. Pankhurst Q A, Thanh N K T, Jones S K and Dobson J 2009 Progress in applications of magnetic nanoparticles in biomedicine J. Phys. D: Appl. Phys. 22 224001
3. Liu W and Frank J A 2009 Detection and quantification of magnetically labeled cells by cellular MRI Eur. J. Radiol. 70 258-64
4. Bulte J W 2009 In vivo MRI cell tracking: clinical studies AJR Am. J. Roentgenol. 193 314-25
5. Beckmann N et al 2009 In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1 272-98
6. Tang T Y et al 2009 Iron oxide particles for atheroma imaging Arterioscler. Thromb. Vasc. Biol. 29 1001-8
7. Thiesen B and Jordan A 2008 Clinical applications of magnetic nanoparticles for hyperthermia Int. J. Hyperthermia 24 467-74
8. Souza G R et al Three-dimensional tissue culture based on magnetic cell levitation Nat. Nanotechnol. 5 291-6
9. Akiyama H, Ito A, Kawabe Y and Kamihira M 2009 Fabrication of complex three-dimensional tissue architectures using a magnetic force-based cell patterning technique Biomed. Microdevices 11 713-21
10. Weissleder R et al 1989 Superparamagnetic iron oxide: pharmacokinetics and toxicity AJR Am. J. Roentgenol. 152 167-73
11. Pouliquen D, Le Jeune J J, Perdrisot R, Ermias A and Jallet P 1991 Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism Magn. Reson. Imaging 9 275-83
12. Laurent S et al 2008 Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications Chem. Rev. 108 2064-110
13. MacKenzie E L, Iwasaki K and Tsuji Y 2008 Intracellular iron transport and storage: from molecular mechanisms to health implications Antioxid. Redox Signal. 10 997-1030
14. Briley-Saebo K, Bjornerud A, Grant D, Ahlstrom H, Berg T and Kindberg G M 2004 Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging Cell Tissue Res. 316 315-23
15. Okon E et al 1994 Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study Lab. Invest. 71 895-903
16. Schulze E, Ferrucci J T Jr, Poss K, Lapointe L, Bogdanova A and Weissleder R 1995 Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro Invest. Radiol. 30 604-10
17. Kurz T, Terman A, Gustafsson B and Brunk U T 2008 Lysosomes in iron metabolism, ageing and apoptosis Histochem. Cell Biol. 129 389-406
18. Wilhelm C and Gazeau F 2008 Universal cell labelling with anionic magnetic nanoparticles Biomaterials 29 3161-74
19. Ohkuma S and Poole B 1978 Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents Proc. Natl Acad. Sci. USA 75 3327-31
20. Ohkuma S, Moriyama Y and Takano T 1982 Identification and characterization of a proton pump on lysosomes by fluorescein-isothiocyanate- dextran fluorescence Proc. Natl Acad. Sci. USA 79 2758-62
21. Arbab A S, Wilson L B, Ashari P, Jordan E K, Lewis B K and Frank J A 2005 A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging NMR Biomed. 18 383-9
22. Massart R 1981 Preparation of aqueous magnetic liquids in alkaline and acidic media IEEE Trans. Magn. 17 1247-48
23. Massart R D, E, Cabuil V and Hasmonay E 1995 Preparation and properties of monodisperse magnetic fluids J. Magn. Magn. Mater. 149 1-5
24. Bourrinet P et al 2006 Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent Invest. Radiol. 41 313-24
25. Bernd H, De Kerviler E, Gaillard S and Bonnemain B 2009 Safety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent: comprehensive analysis of a clinical development program Invest. Radiol. 44 336-42
26. Sigovan M et al 2009 Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model Radiology 252 401-9
27. Gazeau F et al 1999 Magnetic resonance of nanoparticles in a ferrofluid: evidence of thermofluctuational effects J. Magn. Magn. Mater. 202 535-46
28. Wilhelm C, Gazeau F and Bacri J C 2002 Magnetophoresis and ferromagnetic resonance of magnetically labeled cells Eur. Biophys. J. 31 118-25
29. Beaumont C and Delaby C 2009 Recycling iron in normal and pathological states Sem. Hematol. 46 328-38
30. Wilhelm C, Cebers A, Bacri J C and Gazeau F 2003 Deformation of intracellular endosomes under a magnetic field Eur. Biophys. J. 32 655-60
31. Hower V et al 2009 A general map of iron metabolism and tissue-specific subnetworks Mol. Biosyst. 5 422-43
32. Winterbourn C C 1995 Toxicity of iron and hydrogen peroxide: the Fenton reaction Toxicol. Lett. 82/83 969-74
33. Papanikolaou G and Pantopoulos K 2005 Iron metabolism and toxicity Toxicol. Appl. Pharmacol. 202 199-211
34. BreuerW, ShvartsmanM and Cabantchik Z I 2008 Intracellular labile iron Int. J. Biochem. Cell Biol. 40 350-4
35. Arbab A S et al 2003 Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging Radiology 229 838-46
36. Pawelczyk E, Arbab A S, Pandit S, Hu E and Frank J A 2006 Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging NMR Biomed. 19 581-92
37. Kedziorek D A et al Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles Magn. Reson. Med. 63 1031-43
38. Luciani N, Wilhelm C and Gazeau F 2010 The role of cell-released microvesicles in the intercellular transfer of magnetic nanoparticles in the monocyte/macrophage system Biomaterials 31 7061-9
39. Liu X, Jin W and Theil E C 2003 Opening protein pores with chaotropes enhances Fe reduction and chelation of Fe from the ferritin biomineral Proc. Natl Acad. Sci. USA 100 3653-8
40. 3+ J. Inorg. Biochem. 28 181-7
41. Gazeau F, Levy M and Wilhelm C 2008 Optimizing magnetic nanoparticle design for nanothermotherapy Nanomedicine 3 831-44